SiO2/TiO2-xCx/C的制备、表征及其吸附和可见光催化性能

以SiO2为成核中心,钛酸四丁酯为钛源,分别以多羟基化合物乙二醇、丙三醇、葡萄糖和聚乙烯醇为联接剂,采用水解沉淀法制备了碳掺杂和包覆的多孔SiO2/TiO2-xCx/C可见光响应型光催化剂。采用X-射线衍射(XRD)、透射电子显微镜(TEM)、X-射线光电子能谱(XPS)、傅里叶变换-红外光谱(FTIR)、比表面积(BET)和紫外-可见(UV-Vis)漫反射光谱对样品进行表征。对不同结构样品的形成机理进行了分析。以次甲基蓝(MB)溶液为模拟废水,对样品的吸附性能和可见光催化性能进行了评价。结果表明,多羟基化合物对材料的结构和性能有重要影响。碳的掺杂和包覆使材料的吸收光谱包含了整个可见光区,而多孔结构使材料的吸附性能得到提高。以聚乙烯醇为原料所得样品吸附性能最好,30 min内吸附率达到70%;而以丙三醇为原料所得样品具有最好的可见光催化性能,40 min内次甲基蓝的降解率达到95%。     

生物基化工与材料产业技术的开发与探索

本文阐述了中国石油化工集团公司(中国石化)在生物基化工与材料领域的探索路径和发展战略,介绍了中国石化近年来在生物基单体、生物基材料与可降解材料等领域开展的创新实践及取得的阶段性成果,主要包括乳酸—聚乳酸、丁二酸/二元醇—生物可降解材料、长链二元酸—生物基尼龙以及生物质芳烃—聚对苯二甲酸乙二酯(PET)等技术领域.提出了建立生物基化工与材料科学技术平台、突破关键技术、发展新兴产业等建议.     

Co3O4/UiO-66@α-Al2O3陶瓷膜对VOCs废气的分离催化性能

以α-Al₂O₃为支撑层, UiO-66为分离层, Co₃O₄为催化层, 构建了Co₃O₄/UiO-66@α-Al₂O₃陶瓷膜.对其形貌结构进行了表征, 并研究了其对挥发性有机物(VOCs)的分离催化性能. 结果表明, 该陶瓷膜对喷涂行业废气中苯与吡啶两种主要成分体现出良好的分离性, 透过侧的气体中吡啶与苯的摩尔浓度比值可由给料侧的1提高至17; 体系中引入臭氧后, 给料侧苯的浓度明显降低, 其去除率可达到89%. 透过侧的吡啶去除率仅为27%, 得到了较大程度的保留, 剩余的吡啶经收集后可进行单独的深度处理. Co₃O₄/UiO-66@α-Al₂O₃陶瓷膜在对喷涂行业废气中苯成分高效降解的同时, 能够有效解决喷涂行业废气处理过程中氮氧化物的排放问题, 有望成为喷涂行业废气预处理工艺的理想选择.     

烯烃聚合催化剂的研究进展

获得高性能聚烯烃材料是化学家们不断的追求。烯烃聚合催化剂的结构对其催化性能有重要影响,而聚烯烃的改性则能够改善聚合物实际应用中表面形貌、本体性能中存在的缺陷,如通过改性可增加聚合物韧性、降低聚合物表面的摩擦系数或提升表面能等。 本文系统总结了金属烯烃聚合催化剂研究进展,包括Ziegler-Natta催化剂、茂金属催化剂、非茂金属催化剂的结构及调控策略,探讨了位阻效应、双金属协同效应以及其他效应对催化效果的影响。     

蚕丝基智能纤维及织物：潜力、现状与未来展望

纤维及织物因具有良好的柔性、透气性以及适宜的力学性能而成为人们日常生活必不可少的材料。随着柔性电子器件的快速发展,纤维及织物在其自身优势的基础上,开始被人们赋予智能化特征,使得智能纤维和织物逐渐在可穿戴领域占据一席之地。天然蚕丝具有产量大、机械性能优异和生物可降解的优势。近年来,面向智能应用的蚕丝基纤维与织物逐渐发展,被用于传感、致动、光学器件、能量收集和储能等领域。本文将首先介绍天然蚕丝的层级结构和性能,并介绍各种形貌结构的再生蚕丝材料;然后根据其在智能纤维及织物中应用领域的不同,详细阐述蚕丝基智能纤维及织物的制备方法、性能及工作机制;最后讨论进一步发展所面临的挑战与机会,并对未来前景进行展望。     

液相色谱-四极杆/飞行时间质谱法分析29种芬太尼类物质及其碎裂机理北大核心CSCD

芬太尼类物质品种繁多,自我国整类列管后,整类检测是该领域的重点和难点。该文详细研究了29种化合物的二级质谱碎片离子碎裂机理,总结出芬太尼类物质的碎裂规律和特点,为芬太尼物质的整类筛查检测提供参考。建立了分析29种芬太尼类物质的一级和二级质谱库的定性方法,建立了液相色谱-四极杆/飞行时间质谱(LC-QTOF-MS)检测29种芬太尼类物质的定量方法。药品和白色粉末类、蛋白质和乳饮料类样品经乙腈提取,含糖固体或粉末类、饮用水类、果蔬饮料类、保健饮料类、茶饮料类、酒类样品经10%乙腈水溶液提取,提取液经涡旋、离心和过膜后,采用Kinetex C18色谱柱(100 mm×2.1 mm,2.6μm)分离,以乙腈和0.08%甲酸水溶液为流动相进行梯度洗脱,采用四极杆/飞行时间质谱,在正离子模式下,外标法定量检测。结果表明,29种芬太尼类物质在1~20μg/L范围内线性关系良好,相关系数均大于0.995,检出限(LOQ)均为0.01 mg/kg,定量限(LOQ)均为0.05 mg/kg,在降糖药、露露、葡萄糖粉、珍露保健饮料和巧克力样品中3个加标水平平均回收率为85.2%~112.9%,相对标准偏差(RSD)为1.9%~19.8%(n=6)。该方法操作简单,耗时短,灵敏度高,稳定性好,检测品种覆盖范围广,适用于药品类、含糖固体或粉末类、饮料类、饮用水类和酒类等样品中29芬太尼类物质的定性和定量检测。     

新型氮杂环卡宾催化剂的合成及其在烯烃的自由基氟烷基酰化反应中的应用研究

以环庚酮及环己（庚）胺为起始原料,经溴代、环化、脱硫等反应,以良好的收率合成了环烷基取代的新型噻唑骨架的氮杂环卡宾催化剂。结果表明,在该催化剂催化下成功地实现了烯烃的自由基氟烷基酰化反应,以中等的收率完成了三种类型的γ-氟烷基取代酮的高效合成。所得化合物通过¹H NMR, ¹³C NMR, ¹⁹F NMR和HR-MS（ESI-TOF）进行表征。     

Enhanced Oral Absorption of Icaritin by Using Mixed Polymeric Micelles Prepared with a Creative Acid-Base Shift Method

The purpose of this study was to develop mixed polymeric micelles with high drug loading capacity to improve the oral bioavailability of icaritin with Soluplus^® and Poloxamer 407 using a creative acid-base shift (ABS) method, which exhibits the advantages of exclusion of organic solvents, high drug loading and ease of scaling-up. The feasibility of the ABS method was successfully demonstrated by studies of icaritin-loaded polymeric micelles (IPMs). The prepared IPMs were characterized to have a spherical shape with a size of 72.74 ± 0.51 nm, and 13.18% drug loading content. In vitro release tests confirmed the faster release of icaritin from IPMs compared to an oil suspension. Furthermore, bioavailability of icaritin in IPMs in beagle dogs displayed a 14.9-fold increase when compared with the oil suspension. Transcellular transport studies of IPMs across Caco-2 cell monolayers confirmed that the IPMs were endocytosed in their intact forms through macropinocytosis, clathrin-, and caveolae-mediated pathways. In conclusion, the results suggested that the mixed micelles of Soluplus^® and Poloxamer 407 could be a feasible drug delivery system to enhance oral bioavailability of icaritin, and the ABS method might be a promising technology for the preparation of polymeric micelles to encapsulate poorly water-soluble weakly acidic and alkaline drugs.     

Design,Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway. In this study, based on the molecular hybridization strategy, a new structural framework with an N-aryl-N’-arylmethylurea scaffold was designed, and 16 new target compounds were synthesized and evaluated for their antiproliferative activities against four different cancer cell lines A549, MCF7, HCT116, PC3, and human liver normal cell line HL7702. The results have shown seven compounds with 1-methylpiperidin-4-yl groups having excellent activities against all four cancer cell lines, and they exhibited scarcely any activities against HL7702. Among them, compound 9b and 9d showed greatly excellent activity against the four kinds of cells, and the IC₅₀ for MCF7 and PC3 cell lines were even less than 3 μM.